Targeted radiation added to hormone therapy could extend control of advanced prostate cancer
NCT ID NCT06832774
Summary
This study is testing if adding targeted radiation to standard hormone therapy helps control advanced prostate cancer for a longer time. It will include about 192 men newly diagnosed with prostate cancer that has spread. After initial hormone therapy, doctors will use a special scan to find remaining cancer spots and randomly assign some patients to receive precise radiation to those areas.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER METASTATIC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai General Hospital
RECRUITINGShanghai, Shanghai Municipality, 200080, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.